Dr. Andrew F. Trainer, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Missouri, Kansas City, School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,086
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: University of Missouri, Kansas City, School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
NE license 22391
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Nebraska Methodist Hospital Omaha, NE
- Chi Health Lakeside Omaha, NE
- Methodist Jennie Edmundson Council Bluffs, IA
- Myrtue Medical Center Harlan, IA
- Boys Town National Research Hospital Boys Town, NE
Medical groups
- Urology Center PC (41 clinicians)
- Adult and Pediatric Urology PC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,086
- Services billed
- 50,799
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, testosterone undecanoate, 1 mg | 34,500 | 12 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,475 | 56 |
| Injection, denosumab, 1 mg | 2,820 | 27 |
| Detection test by nucleic acid for organism, amplified probe technique | 1,209 | 78 |
| Automated urinalysis test | 802 | 541 |
| Established patient office or other outpatient visit, 20-29 minutes | 775 | 569 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 500 | 142 |
| Established patient office or other outpatient visit, 30-39 minutes | 478 | 339 |
| Detection test for candida species (yeast), amplified probe technique | 465 | 78 |
| Insertion of needle into vein for collection of blood sample | 396 | 301 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Omaha, NE | 850 |
| Finasteride Other prescribers in Omaha, NE | 181 |
| Myrbetriq (mirabegron) Other prescribers in Omaha, NE | 151 |
| Gemtesa (vibegron) Other prescribers in Omaha, NE | 107 |
| Methenamine Hippurate Other prescribers in Omaha, NE | 102 |
| Cephalexin Other prescribers in Omaha, NE | 93 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Omaha, NE | 92 |
| Potassium Citrate Er (potassium citrate) Other prescribers in Omaha, NE | 76 |
| Orgovyx (relugolix) | 68 |
| Tramadol Hcl Other prescribers in Omaha, NE | 49 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 79 payments worth $1,751 in total to this clinician.
| Procept Biorobotics Corporation | $650 |
|---|---|
| Sumitomo Pharma America, Inc. | $369 |
| Urogen Pharma, Inc. | $141 |
| Janssen Biotech, Inc. | $90.70 |
| Seagen Inc. | $78.99 |
| Progenics Pharmaceuticals, Inc. | $62.01 |
| Tolmar, Inc. | $48.03 |
| Novartis Pharmaceuticals Corporation | $40.18 |
| Food and Beverage | $1,672 |
|---|---|
| Education | $78.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Seagen Inc. Jun 30, 2025 | Education in-kind | $78.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 5 companies. The companies reported $108,501 in research payments for these studies, mostly to the institutions running them.
- Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals As · Recruiting · NCT06510374 - A phase 3 randomized double blind placebo controlled study of PF06821497 mevrometostat with enzalutamide in metastatic castration resistant prostate cancer MEVPRO2
Pfizer Inc. - Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
Dendreon Pharmaceuticals LLC · Recruiting · NCT06134232 - Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Ferring Pharmaceuticals As · Recruiting · NCT06668493 - Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Sumitomo Pharma America, Inc. · Completed · NCT05605964 - An International Prospective Open-label, Multi-center, Randomized Phase III Study comparing [177Lu] Lu-PSMA-617 versus Observation to delay castration or disease recurrence in adult male patients with PSMA positive Ol…
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.